GLP Watchdog

Brello Health vs Mochi Health

Neither Brello Health nor Mochi Health has an FDA warning letter on record. No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate, while Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Brello Health / Mochi Health

Brello Health logo

Brello Health

8.1/10

Mochi Health logo

Mochi Health

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$157.72/moCompounded semaglutide injection, 3-month prepaid plan
$110/moFoundayo (orforglipron) pill
States
40 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Brello Health
Visit Mochi Health

Neither Brello Health nor Mochi Health pays us. Links to them earn nothing. Scores: Brello Health 8.1, Mochi Health 7.1. How we are paid

What the record shows

  1. 01

    Neither Brello Health nor Mochi Health has an FDA warning letter on record.

  2. 02

    Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Mochi Health names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate, while Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

  4. 04

    Only Mochi Health lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.

  5. 05

    Mochi Health covers 10 states Brello Health does not.

  6. 06

    Brello Health holds you to a 3-month prepay (6-month plan optional); Mochi Health states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Brello Health

Mochi Health

Compounded semaglutide injection

$157.72/mo

3-month prepaid plan; not compared

$139/mo

plan terms unclear; not compared

Compounded tirzepatide injection

$176.69/mo

6-month prepaid plan; not compared

$169/mo

plan terms unclear; not compared

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Compounded oral semaglutide
Not sold or not priced

$141/mo

$1,692 a year

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$110/mo

$1,320 a year

Price includes
Medication, clinician visits
Clinician visits, coaching
Billed separately
Not stated
Medication
Cancel any time
No
Yes, stated
Minimum term
3-month prepay (6-month plan optional)
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
Refunds
Full refund before a prescription; $50 fee within 24 hours after; none once dispensed
No refunds for partly used periods; medication is not refundable once sent to the pharmacy

Read off each seller’s own pages. Brello Health: October 25, 2026. Mochi Health: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Brello Health

8.1/10
  • Names its compounding pharmacy
  • Minimum commitment before you can cancel
  • Lowest price is a 3-month prepaid rate
Visit Brello Health

The case for Mochi Health

7.1/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Brello Health does not price
  • Lists 50 states against 40
  • States you can cancel at any time
  • Names no compounding pharmacy
  • Price leaves out medication
Visit Mochi Health

Scores

Brello Health 8.1 · Mochi Health 7.1 out of 10. Six weighted parts.

Value25%

6.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

10.0A
vs
B
8.5

Accessibility10%

8.4A
vs
B
10.0

Support10%

5.5A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Brello Health vs Mochi Health: questions

Neither Brello Health nor Mochi Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Mochi Health names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate, while Mochi Health's $139 comes with plan terms the seller's page leaves unclear. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Brello Health has a minimum term (3-month prepay (6-month plan optional)). Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy.
Neither Brello Health nor Mochi Health pays us. Links to them earn nothing. Scores: Brello Health 8.1, Mochi Health 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks